To Stop or Not, That Is the Question | Anesthesiology | American Society of
Anesthesiologists Skip to Main Content Advertisement Umbrella Alt Text Umbrella Alt Text …

Opioid use disorder (OUD), a leading cause of morbidity and mortality in the USA, can be
effectively treated with buprenorphine. However, the same pharmacologic properties (eg …

Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Objective There is no consensus on the optimal perioperative management of patients on
buprenorphine (BUP) for opioid use disorder (OUD). This article will review the available …

Until recently, the belief that adequate pain management was not achievable while patients
remained on buprenorphine was the impetus for the perioperative discontinuation of …

Buprenorphine has been in clinical use in anaesthesia for several decades. Recently, the
high-dose sublingual formulation (Subutex®, Reckitt Benckiser, Slough, UK) has been …

Interest in the use of buprenorphine as an analgesic has increased in recent years. Its
unique agonist-antagonist properties makes it a useful analgesic with a potential lower …

Buprenorphine maintenance therapy patients frequently have severe postoperative pain
due to buprenorphine-induced hyperalgesia and provider use of opioids with limited efficacy …

Background: Starting with approval for clinical use in the treatment of opioid dependence in
October 2002 by the Food and Drug Administration (FDA), buprenorphine has become an …

Objective An increasing number of individuals are prescribed buprenorphine as medication-
assisted treatment for opioid use disorder. Our institution developed guidelines for …